United States Pharmaceuticals

Scilex Holding Co (SCLX)

Track

Scilex Holding Co experienced significant selling activity in late December 2025, with the most recent transaction occurring on December 30. These divestments followed a period of earlier buying interest from various insiders throughout 2024. No further trading has been reported since the end of that year.
Ticker: SCLX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Scilex Holding Co. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
Scilex Holding Co Large shareholder
Transaction date
Sale
Price
387.81
Quantity 81,733 +2.0%
Value US$4,670,811
3.7
Scilex Holding Co Large shareholder
Transaction date
Sale
Price
94.16
Quantity 4,648 +13.4%
Value US$3,582,488
3.7
Scilex Holding Co Large shareholder
Transaction date
Sale
Price
114.63
Quantity 44,407 -9.9%
Value US$1,638,008
3.1
SHAH JAISIM See Remarks Executive Director
Transaction date
Purchase
Price
0.46
Quantity 30,000 +27.4%
Value US$13,800
1.9
Ji Henry Executive Chairperson Executive Director
Transaction date
Purchase
Price
0.94
Quantity 8,888 +2.9%
Value US$8,351
3.1
SHAH JAISIM See Remarks Executive Director
Transaction date
Purchase
Price
0.99
Quantity 32,000 +41.4%
Value US$31,670
1.2
Followwill Dorman Non-Executive Director
Transaction date
Purchase
Price
0.99
Quantity 1,000 +76.9%
Value US$990
3.4
Chun Jay Non-Executive Director
Transaction date
Purchase
Price
0.95
Quantity 5,000 +4.7%
Value US$4,750
1.9
Ji Henry Executive Chairperson Executive Director
Transaction date
Purchase
Price
0.97
Quantity 10,000 +20.0%
Value US$9,710
0.5
Wu Yue Alexander Non-Executive Director
Transaction date
Purchase
Price
0.95
Quantity 20,000 +400.0%
Value US$18,992
0.5
Lemus David Non-Executive Director
Transaction date
Purchase
Price
0.90
Quantity 2,000 +inf%
Value US$1,800
3.1
SHAH JAISIM See Remarks Executive Director
Transaction date
Purchase
Price
0.99
Quantity 30,000 +63.4%
Value US$29,751
2.8
Ma Stephen Hoi Chief Financial Officer Officer
Transaction date
Purchase
Price
0.97
Quantity 6,700 +41.5%
Value US$6,499
2.8
Ma Stephen Hoi Chief Financial Officer Officer
Transaction date
Purchase
Price
0.88
Quantity 14,140 +inf%
Value US$12,443
1.9
Ji Henry Executive Chairperson Executive Director
Transaction date
Purchase
Price
0.88
Quantity 50,000 +71428.6%
Value US$43,985
3.1
SHAH JAISIM See Remarks Executive Director
Transaction date
Purchase
Price
0.92
Quantity 56,939 +57.5%
Value US$52,099
3.4
Chun Jay Non-Executive Director
Transaction date
Purchase
Price
0.90
Quantity 57,500 +127.8%
Value US$51,641
3.1
SHAH JAISIM See Remarks Executive Director
Transaction date
Purchase
Price
0.84
Quantity 83,061 +523.0%
Value US$69,846
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-30 2025-12-30 S Sale
3.7
Scilex Holding Co
Large shareholder
81,733 +2.0%
387.81
US$4,670,811 		81,733 +2.0% 387.81 US$4,670,811
2025-12-30 2025-12-29 S Sale
3.7
Scilex Holding Co
Large shareholder
4,648 +13.4%
94.16
US$3,582,488 		4,648 +13.4% 94.16 US$3,582,488
2025-12-30 2025-12-26 S Sale
3.7
Scilex Holding Co
Large shareholder
44,407 -9.9%
114.63
US$1,638,008 		44,407 -9.9% 114.63 US$1,638,008
2024-12-18 2024-12-18 B Purchase
3.1
SHAH JAISIM

See Remarks

Executive Director
30,000 +27.4%
0.46
US$13,800 		30,000 +27.4% 0.46 US$13,800
2024-10-31 2024-10-31 B Purchase
1.9
Ji Henry

Executive Chairperson

Executive Director
8,888 +2.9%
0.94
US$8,351 		8,888 +2.9% 0.94 US$8,351
2024-10-29 2024-10-29 B Purchase
3.1
SHAH JAISIM

See Remarks

Executive Director
32,000 +41.4%
0.99
US$31,670 		32,000 +41.4% 0.99 US$31,670
2024-10-18 2024-10-18 B Purchase
1.2
Followwill Dorman
Non-Executive Director
1,000 +76.9%
0.99
US$990 		1,000 +76.9% 0.99 US$990
2024-10-18 2024-10-18 B Purchase
3.4
Chun Jay
Non-Executive Director
5,000 +4.7%
0.95
US$4,750 		5,000 +4.7% 0.95 US$4,750
2024-10-18 2024-10-17 B Purchase
1.9
Ji Henry

Executive Chairperson

Executive Director
10,000 +20.0%
0.97
US$9,710 		10,000 +20.0% 0.97 US$9,710
2024-10-18 2024-10-17 B Purchase
0.5
Wu Yue Alexander
Non-Executive Director
20,000 +400.0%
0.95
US$18,992 		20,000 +400.0% 0.95 US$18,992
2024-10-18 2024-10-17 B Purchase
0.5
Lemus David
Non-Executive Director
2,000 +inf%
0.90
US$1,800 		2,000 +inf% 0.90 US$1,800
2024-10-17 2024-10-16 B Purchase
3.1
SHAH JAISIM

See Remarks

Executive Director
30,000 +63.4%
0.99
US$29,751 		30,000 +63.4% 0.99 US$29,751
2024-10-17 2024-10-16 B Purchase
2.8
Ma Stephen Hoi

Chief Financial Officer

Officer
6,700 +41.5%
0.97
US$6,499 		6,700 +41.5% 0.97 US$6,499
2024-05-17 2024-05-17 B Purchase
2.8
Ma Stephen Hoi

Chief Financial Officer

Officer
14,140 +inf%
0.88
US$12,443 		14,140 +inf% 0.88 US$12,443
2024-05-17 2024-05-17 B Purchase
1.9
Ji Henry

Executive Chairperson

Executive Director
50,000 +71428.6%
0.88
US$43,985 		50,000 +71428.6% 0.88 US$43,985
2024-05-17 2024-05-17 B Purchase
3.1
SHAH JAISIM

See Remarks

Executive Director
56,939 +57.5%
0.92
US$52,099 		56,939 +57.5% 0.92 US$52,099
2024-05-17 2024-05-17 B Purchase
3.4
Chun Jay
Non-Executive Director
57,500 +127.8%
0.90
US$51,641 		57,500 +127.8% 0.90 US$51,641
2024-05-17 2024-05-16 B Purchase
3.1
SHAH JAISIM

See Remarks

Executive Director
83,061 +523.0%
0.84
US$69,846 		83,061 +523.0% 0.84 US$69,846
2023-09-25 2023-09-21 S Sale
Sorrento Therapeutics, Inc.
Large shareholder
60,068,585
0.00
US$0 		60,068,585 0.00 US$0
Explore more

More insider trading research around Scilex Holding Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America